References
- Aguiree F, Brown A, Cho NH, et al. IDF diabetes atlas. https://www.diabetesatlas.org/en/. 2019.
- Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013;2013:653789. doi:https://doi.org/10.1155/2013/653789.
- van der Heijden AA, Van't Riet E, Bot SD, et al. Risk of a recurrent cardiovascular event in individuals with type 2 diabetes or intermediate hyperglycemia: the Hoorn Study. Diabetes Care. 2013;36(11):3498–3502. doi:https://doi.org/10.2337/dc12-2691.
- Norhammar A, Lindback J, Ryden L, Wallentin L, Stenestrand U, on behalf of the Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA) Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart (British Cardiac Society). 2006;93(12):1577–1583. doi:https://doi.org/10.1136/hrt.2006.097956.
- Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2005;45(1 Suppl 1)A5-7, :S1–S280.
- van Dooren FE, Nefs G, Schram MT, Verhey FR, Denollet J, Pouwer F. Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS One. 2013;8(3):e57058. doi:https://doi.org/10.1371/journal.pone.0057058.
- Jackson CA, Jones NR, Walker JJ, Scottish Diabetes Research Network Epidemiology Group, et al. Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia. 2012;55(11):2938–2945. doi:https://doi.org/10.1007/s00125-012-2667-1.
- Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–887. e881. doi:https://doi.org/10.1016/j.amjmed.2011.12.013.
- Leritz EC, McGlinchey RE, Kellison I, Rudolph JL, Milberg WP. Cardiovascular Disease Risk Factors and Cognition in the Elderly. Curr Cardiovasc Risk Rep. 2011;5(5):407–412. doi:https://doi.org/10.1007/s12170-011-0189-x.
- Goldstein CM, Gathright EC, Garcia S. Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the integrated care team. Patient Prefer Adherence. 2017;11:547–559. doi:https://doi.org/10.2147/PPA.S127277.
- Hegel M, Barrett J, Oxman T. Training physicians in problem solving treatment of depressive disorders in primary care: lessons learned from the “Treatment Effectiveness Project. Fam Syst Health. 2000;18(4):423–435. doi:https://doi.org/10.1037/h0091866.
- Kim YY, Lee JS, Kang HJ, Park SM. Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients. Sci Rep. 2018;8(1):12190. doi:https://doi.org/10.1038/s41598-018-30740-y.
- Gibson TB, Song X, Alemayehu B, et al. Cost sharing, adherence, and health outcomes in patients with diabetes. Am J Manag Care. 2010;16(8):589–600.
- Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109. doi:https://doi.org/10.1016/j.clinthera.2011.01.019.
- Gathright EC, Goldstein CM, Josephson RA, Hughes JW. Depression increases the risk of mortality in patients with heart failure: a meta-analysis. J Psychosom Res. 2017;94:82–89. doi:https://doi.org/10.1016/j.jpsychores.2017.01.010.
- Osborn CY, Mayberry LS, Kim JM. Medication adherence may be more important than other behaviours for optimizing glycaemic control among low-income adults. J Clin Pharm Ther. 2016;41(3):256–259. doi:https://doi.org/10.1111/jcpt.12360.
- DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207–218. doi:https://doi.org/10.1037/0278-6133.23.2.207.
- Miller TA, Dimatteo MR. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes. 2013;6:421–426. doi:https://doi.org/10.2147/DMSO.S36368.
- McQuaid EL, Landier W. Cultural issues in medication adherence: disparities and directions. J Gen Intern Med. 2018;33(2):200–206. doi:https://doi.org/10.1007/s11606-017-4199-3.
- Brunton SA, Polonsky WH. Hot topics in primary care: medication adherence in Type 2 diabetes mellitus: real-world strategies for addressing a common problem. J Fam Pract. 2017;66(4 Suppl):S46–S51.
- Yoshikawa H, Aber JL, Beardslee WR. The effects of poverty on the mental, emotional, and behavioral health of children and youth: implications for prevention. Am Psychol. 2012;67(4):272–284. doi:https://doi.org/10.1037/a0028015.
- Grover A, Joshi A. An overview of chronic disease models: a systematic literature review. Glob J Health Sci. 2014;7(2):210–227. doi:https://doi.org/10.5539/gjhs.v7n2p210.
- Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54–65. doi:https://doi.org/10.3121/cmr.2013.1113.
- Kim J, Bushnell CD, Lee HS, Han SW. Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea. Hypertension (Dallas, Tex: 1979). 2018;72(2):391–398. doi:https://doi.org/10.1161/HYPERTENSIONAHA.118.11139.
- Spreafico M, Gasperoni F, Barbati G, et al. Adherence to disease-modifying therapy in patients hospitalized for HF: findings from a community-based study. Am J Cardiovasc Drugs. 2020;20(2):179–190. doi:https://doi.org/10.1007/s40256-019-00367-z.
- Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117(8):1028–1036. doi:https://doi.org/10.1161/CIRCULATIONAHA.107.706820.
- de Vries McClintock HF, Boyle KB, Rooney K, Bogner HR. Diabetes and depression care: a randomized controlled pilot trial. Am J Health Behav. 2016;40(4):503–513. doi:https://doi.org/10.5993/AJHB.40.4.12.
- Kahn R, Alperin P, Eddy D, et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet. 2010;375(9723):1365–1374. doi:https://doi.org/10.1016/S0140-6736(09)62162-0.
- Angst J. Clinical course of affective disorders. In: Helgason T., Daly R.J, eds. Depressive Illness. Berlin, Heidelberg: Springer; 1988. doi:https://doi.org/10.1007/978-3-642-73546-2_1.
- Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the mini-mental state examination by age and educational level. Jama. 1993;269(18):2386–2391.
- Stewart AL, Hays RD, Ware JE. Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988;26(7):724–735. doi:https://doi.org/10.1097/00005650-198807000-00007.
- Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262(7):914–919.
- Stadnyk K, Calder J, Rockwood K. Testing the measurement properties of the Short Form-36 Health Survey in a frail elderly population. Journal of Clinical Epidemiology. 1998;51(10):827–835. doi:https://doi.org/10.1016/S0895-4356(98)00061-4.
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:https://doi.org/10.1046/j.1525-1497.2001.016009606.x.
- Moridani MY, Verjee Z, Allen LC. Analytical evaluation of hemoglobin A(1c) dual kit assay on Bio-Rad Variant II: an automated HPLC hemoglobin analyzer for the management of diabetic patients. Clin Biochem. 2003;36(4):317–320. doi:https://doi.org/10.1016/S0009-9120(03)00013-4.
- American Heart Association. Blood pressure testing and assessment. www.americanheart.org. Published 2016. Accessed April, 2017.
- Stineman MG, Kurz AE, Kelleher D, Kennedy BL. The patient’s view of recovery: an emerging tool for empowerment through self-knowledge. Disabil Rehabil. 2008;30(9):679–688. doi:https://doi.org/10.1080/09638280701456112.
- Bogner HR, Ford DE, Gallo JJ. The role of cardiovascular disease in the identification and management of depression by primary care physicians. Am J Geriatr Psychiatry. 2006;14(1):71–78. doi:https://doi.org/10.1097/01.JGP.0000192479.82189.e1.
- Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG, Bentley ME. Pill count adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr. 2005;135(5):1093–1101. doi:https://doi.org/10.1093/jn/135.5.1093.
- Lee MS, Lee HY, Kang SG, et al. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. J Affect Disord. 2010;123(1-3):216–221. doi:https://doi.org/10.1016/j.jad.2009.10.002.
- Saldaña J. The coding manual for qualitative researchers. London (UK): Sage Publications; 2009.
- Boeije H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Quality and Quantity. 2002;36(4):391–409. doi:https://doi.org/10.1023/A:1020909529486.
- Jackson BM, Gutierrez ML, Relyea GE, et al. Unmet primary care needs in diabetic patients with multimorbidity in a medically underserved area. Health Serv Res Manag Epidemiol. 2017;4. doi:https://doi.org/10.1177/2333392817702760.
- Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38. doi:https://doi.org/10.1186/s12875-016-0440-0.
- Sawkin MT, Deppe SJ, Thelen J, Stoner SC, Dietz CA, Rasu RS. Health literacy and medication adherence among patients treated in a free health clinic: a pilot study. Health Serv Res Manag Epidemiol. 2015;2. doi:https://doi.org/10.1177/2333392815589094.
- Kronish IM, Diefenbach MA, Edmondson DE, Phillips LA, Fei K, Horowitz CR. Key barriers to medication adherence in survivors of strokes and transient ischemic attacks. J Gen Intern Med. 2013;28(5):675–682. doi:https://doi.org/10.1007/s11606-012-2308-x.
- Hincapie AL, Gupta V, Brown SA, Metzger AH. Exploring perceived barriers to medication adherence and the use of mobile technology in underserved patients with chronic conditions. J Pharm Pract. 2019;32(2):147–153. doi:https://doi.org/10.1177/0897190017744953.
- Burkholder R, Linn E. So simple, so hard: taking medication as directed. Res Social Adm Pharm. 2017;13(1):233–249. doi:https://doi.org/10.1016/j.sapharm.2016.02.002.
- Bazargan M, Smith J, Movassaghi M, et al. Polypharmacy among underserved older African American adults. J Aging Res. 2017;2017:6026358. doi:https://doi.org/10.1155/2017/6026358.
- Fischer MA, Choudhry NK, Brill G, et al. Trouble getting started: predictors of primary medication nonadherence. Am J Med. 2011;124((11):1081.e1089.
- Medicine Io, National Academies of Sciences E, Medicine. A framework for educating health professionals to address the social determinants of health. washington, DC: The National Academies Press; 2016.
- Salazar-Fraile J, Sempere-Verdu E, Perez-Hoyos S, Tabares-Seisdedos R, Gomez-Beneyto M. Five interpersonal factors are predictive of the response to treatment of major depression with antidepressants in primary care. Front Psychiatry. 2018;9:416. doi:https://doi.org/10.3389/fpsyt.2018.00416.
- Rajpura J, Nayak R. Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden. JMCP. 2014;20(1):58–65. doi:https://doi.org/10.18553/jmcp.2014.20.1.58.
- Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12(4):387–398. doi:https://doi.org/10.1080/09540120050123783.
- Smith AUS. smartphone use in 2015. http://www.pewinternet.org/2015/04/01/us-smartphone-use-in-2015.2015.
- Kitsiou S, Pare G, Jaana M, Gerber B. Effectiveness of mHealth interventions for patients with diabetes: an overview of systematic reviews. PLoS One. 2017;12(3):e0173160. doi:https://doi.org/10.1371/journal.pone.0173160.
- Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. The Cochrane Database of Systematic Reviews. 2014;11(2):Cd000011.
- Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the chronic care model in the new millennium. Health Aff (Millwood)). 2009;28(1):75–85. doi:https://doi.org/10.1377/hlthaff.28.1.75.
- Dehghani-Tafti A, Mazloomy Mahmoodabad SS, Morowatisharifabad MA, Afkhami Ardakani M, Rezaeipandari H, Lotfi MH. Determinants of self-care in diabetic patients based on health belief model. Glob J Health Sci. 2015;7(5):33–42. doi:https://doi.org/10.5539/gjhs.v7n5p33.
- George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol. 2000;50(2):166–171. doi:https://doi.org/10.1046/j.1365-2125.2000.00244.x.
- Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–1090. doi:https://doi.org/10.1016/S0149-2918(99)80026-5.
- Campbell JP, Maxey VA, Watson WA. Hawthorne effect: implications for prehospital research. Annals of Emergency Medicine. 1995;26(5):590–594. doi:https://doi.org/10.1016/S0196-0644(95)70009-9.
- Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55(12):1128–1132. doi:https://doi.org/10.1001/archpsyc.55.12.1128.
- Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123(5):894–900. doi:https://doi.org/10.1093/oxfordjournals.aje.a114319.
- Tretli S, Lund-Larsen PG, Foss OP. Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county. J Epidemiol Community Health. 1982;36(4):269–273. doi:https://doi.org/10.1136/jech.36.4.269.
- Doshi T, Smalls BL, Williams JS, Wolfman TE, Egede LE. Socioeconomic status and cardiovascular risk control in adults with diabetes. Am J Med Sci. 2016;352(1):36–44. doi:https://doi.org/10.1016/j.amjms.2016.03.020.
- Mouton CP, Hayden M, Southerland JH. Cardiovascular health disparities in underserved populations. Prim Care. 2017;44(1):e37–e71. doi:https://doi.org/10.1016/j.pop.2016.09.019.